Neuro-Oncology Reviews

Volume 28 Number 7
10 March 2026

Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 7, 10 March

...

Shlobin NA, Hasner MC, Karschnia P, Widhalm G, Petrescu GED, Schucht P, Picart T, Neidert MC, Gempt J, Grossman R, Jakola AS, Jenkinson MD, Goldbrunner R, Weller M, Duerinck J, Broekman MLD.
Ethical considerations in randomization for neurosurgical oncology trials: A scoping review.
Neurooncol Pract. 2025 Aug 16;13(1):3-13. doi: 10.1093/nop/npaf085. PMID: 41798128˰ ˍ

Riaz I, Ali EA, Sial M, Alam MM, Khan C, Khan S, Riaz M.
Efficacy and safety of awake craniotomy versus general anesthesia for glioma resection: A systematic review.
Surg Neurol Int. 2026 Feb 6;17:66. doi: 10.25259/SNI_1102_2025. PMID: 41783186. ˍ

Yi J, Wen J, Wang N, Yuan M, Leng H, Chen H.
Influence of diabetes on survival of patients with glioma: a meta-analysis.
Front Endocrinol (Lausanne). 2026 Feb 12;17:1667242. doi: 10.3389/fendo.2026.1667242. PMID: 41767392. ˍ

Padilla F, Arvanitis C, Bollard CM, Gallus M, De Groot J, Klein RS, Ransohoff RM, Sonabend AM, Okada H.
Focused ultrasound-enhanced cell therapy for brain tumors: Summary of roundtable discussions.
Neurooncol Adv. 2026 Feb 14;8(1):vdag026. doi: 10.1093/noajnl/vdag026. PMID: 41773179. ˍ

Li Y, Qin X, Liang C, Wang L.
Progress in the research and development of oncolytic virus therapies.
Front Pharmacol. 2026 Feb 19;17:1751206. doi: 10.3389/fphar.2026.1751206. PMID: 41800095. ˍ

Gonzales-Portillo D, Vashi B, Bains Williams K, Cervantes J.
Metformin Renders Survival Advantage to Patients with Glioblastoma Multiforme.
Neurol Int. 2026 Feb 24;18(3):40. doi: 10.3390/neurolint18030040. PMID: 41893042. ˍ